Medical Therapy for Gastroesophageal Reflux Disease

Howard, 1992, Epidemiology of gastro-esophageal reflux disease, World J Surg, 16, 288, 10.1007/BF02071535 Richter, 2000, Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications, Am J Gastroenterol, 95, 368 Raiha, 1992, Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly, J Am Geriatr Soc, 40, 1209, 10.1111/j.1532-5415.1992.tb03643.x Lagergren, 1999, Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma, N Engl J Med, 340, 825, 10.1056/NEJM199903183401101 Locke, 1997, Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota, Gastroenterology, 112, 1448, 10.1016/S0016-5085(97)70025-8 Richter, 1997, Long-term management of gastroesophageal reflux disease and its complications, Am J Gastroenterol, 92, 30S Katz, 1999, Treatment of gastroesophageal reflux disease: use of algorithms to aid in management, Am J Gastroenterol, 94, S3, 10.1016/S0002-9270(99)00656-5 Sonnenberg, 1982, Salivary secretion in reflux esophagitis, Gastroenterology, 83, 889, 10.1016/S0016-5085(82)80021-8 Piotrowski, 1996, Saliva and esophagoprotection [letter], Gastroenterology, 111, 834, 10.1053/gast.1996.v111.agast961110834 Holloway, 1990, Pathophysiology of gastroesophageal reflux: lower esophageal sphincter dysfunction in gastroesophageal disease, Gastroenterol Clin North Am, 19, 517, 10.1016/S0889-8553(21)00654-3 Mittal, 1995, Transient lower esophageal sphincter relaxation, Gastroenterology, 109, 601, 10.1016/0016-5085(95)90351-8 Hinder, 1999, Laparoscopic antireflux surgery-it's a wrap, Dig Surg, 16, 7, 10.1159/000018686 Morales, 1999, Barrett's esophagus: update on screening, surveillance, and treatment, Arch Intern Med, 159, 1411, 10.1001/archinte.159.13.1411 Harris, 1997, Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition, Am J Med, 102, 78, 10.1016/S0002-9343(96)00301-4 DeVault, 1999, Overview of medical therapy for gastroesophageal reflux disease, Gastroenterol Clin North Am, 28, 831, 10.1016/S0889-8553(05)70092-3 Hamilton, 1988, Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid, Dig Dis Sci, 33, 518, 10.1007/BF01798350 DeVault, 1999, Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease, Am J Gastroenterol, 94, 1434, 10.1111/j.1572-0241.1999.1123_a.x Wolfe, 2000, Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome, Gastroenterology, 118, S9, 10.1016/S0016-5085(00)70004-7 Sontag, 1990, The medical management of reflux esophagitis: role of antacids and acid inhibition, Gastroenterol Clin North Am, 19, 683, 10.1016/S0889-8553(21)00664-6 Castell, 1998, Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease, Am J Gastroenterol, 93, 547, 10.1111/j.1572-0241.1998.163_b.x Castell, 1999, My approach to the difficult GERD patient, Eur J Gastroenterol Hepatol, 11, S17 Williams, 1998, An important drug interaction, Can J Gastroenterol, 12, 535 Piquette, 1999, Torsade de pointes induced by cisapride/clarithromycin interaction, Ann Pharmacother, 33, 22, 10.1345/aph.18107 Bardhan, 1999, Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine, BMJ, 318, 502, 10.1136/bmj.318.7182.502 Kromer, 1999, Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis, Pharmacology, 59, 57, 10.1159/000028306 Maton, 1999, Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial, Aliment Pharmacol Ther, 13, 819, 10.1046/j.1365-2036.1999.00527.x Peghini, 1998, Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects, Gastroenterology, 115, 1335, 10.1016/S0016-5085(98)70010-1 Tutuian, 2000, A PPI is a PPI is a PPI: lessons from prolonged intragastric pH monitoring [abstract], Gastroenterology, 118, A17, 10.1016/S0016-5085(00)82137-X Termanini, 1998, Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome, Am J Med, 104, 422, 10.1016/S0002-9343(98)00087-4 Vigneri, 1995, A comparison of five maintenance therapies for reflux esophagitis, N Engl J Med, 333, 1106, 10.1056/NEJM199510263331703 Robinson, 1996, Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: a randomized, double-blind, placebo-controlled trial, Ann Intern Med, 124, 859, 10.7326/0003-4819-124-10-199605150-00001 Harris, 1997, Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis, Am J Gastroenterol, 92, 2179 Ofman, 2000, The clinical and economic impact of competing management strategies for GERD [abstract], Gastroenterology, 118, A215, 10.1016/S0016-5085(00)82935-2 Kuipers, 1996, Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication, N Engl J Med, 334, 1018, 10.1056/NEJM199604183341603 Labenz, 1997, Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis, Gastroenterology, 112, 1442, 10.1016/S0016-5085(97)70024-6 Ladas, 2000, Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring, Am J Gastroenterol, 95, 374 Lehmann, 1999, Activation of the GABA (B) receptor inhibits transient lower esophageal sphincter relaxations in dogs, Gastroenterology, 117, 1147, 10.1016/S0016-5085(99)70400-2 Lidums, 2000, Control of transient lower esophageal sphincter relaxations by the GABA (B) agonist baclofen in normal subjects, Gastroenterology, 118, 7, 10.1016/S0016-5085(00)70408-2 Al-Sabbagh, 1999, Supraesophageal manifestations of gastroesophageal reflux disease, Semin Gastrointest Dis, 10, 113 Barone, 1999, Domperidone: a peripherally acting dopamine2-receptor antagonist, Ann Pharmacother, 33, 429, 10.1345/aph.18003